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1. Introduction
  The Carilion Clinic Breast Care Center (CCBCC) is 
a patient-centered program led by an experienced 
staff using advanced technology. Total procedures 
performed annually (screening and diagnostic) are 
about 30 000.  Although routine screening and early 
detection can reduce the number of women affected by 
breast cancer, about 66% of women in our community 
are not getting annual mammograms. The CCBCC is 
dedicated to making a difference in the fight against 
breast cancer. An interdisciplinary approach is the key 
to modern breast care. Our team includes radiologists, 
pathologists, surgeons, medical oncologists, radiation 
oncologists, technologists and nurses.  The result is 
state-of-the-art care for patients and families.
Objective: To compare our institution with national benchmark times, and identify rate-limiting 
steps in the process by conducte a retrospective review of the turnaround times in 2009 at the 
Carilion Clinic Breast Care Center (CCBCC).  To evaluate patient satisfaction with the turn around 
times. Methods: A retrospective chart review was performed to evaluate the time intervals 
from abnormal screening mammogram to diagnostic mammogram, diagnostic mammogram to 
biopsy, biopsy to MRI, and MRI to surgery of all patients seen for breast cancer in 2009. A patient 
survey was mailed out to all patients (131) managed from abnormal screening to surgery in 2009, 
assessing their satisfaction with the turnaround times from screening mammogram to call back, 
call back to diagnostic mammogram, diagnostic mammogram to biopsy, biopsy to results call, 
biopsy result to MRI appointment, MRI appointment to surgery consult, and surgery consult to 
surgery; and assessing possible reasons why patients may perceive the process to be delayed. 
The MEANS procedure was applied to evaluate the turnaround times, and a Box and Whisker Plot 
statistical comparison was made between patient satisfaction and turnaround times. Results: The 
mean turnaround time at the CCBCC in 2009 from abnormal screening mammogram to surgery was 
45 d.  This falls within the 75th %ile of the National Quality Measures for Breast Centers (NQMBC), 
established by the National Consortium of Breast Centers (NCBC).  Of 131 surveys mailed out, 57 
were returned (44%).  The patient satisfaction rates for each interval ranged from 96%-100%, with 
an overall satisfaction rate of 98% for abnormal screening mammogram to surgery. Discussion: 
The CCBCC ranks at the 75%ile in overall turnaround times; however, this turnaround time 
included an interval of MRI, not previously measured in NQMBC benchmark. Rate-limiting steps 
were identified as the time from screening mammogram to diagnostic mammogram, and biopsy 
to surgery-specifically, the sub-interval MRI to surgery. Since 2009, the CCBCC has already 
improved the process for obtaining insurance approval and preauthorization for MRIs; and has 
added an additional breast surgeon to share the burden of benign cases, and a nurse practitioner 
to see post-op and follow up patients, improving the accessibility to the primary breast surgeon 
specialist. Consideration should be given to future time interval studies that evaluate breast 
cancer turnaround time including MRI to help establish benchmarks.
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    The Carilion Clinic Breast Care Center is a local and 
national leader in mammography screening. Highlights 
of our program include:
 Dedicated breast imagers - All mammograms are read 
on-site by board-certified radiologists. 
 Experience - Our 21 technologists have over 360 
combined years of experience, and they have provided 
nearly a quarter million mammograms in the last 10 
years.
 Nurse navigation - We provide a dedicated advanced 
practice nurse to support women through diagnosis and 
treatment, serving as a care coordinator.
 High risk program - Genetic testing and counseling is 
available for people who may be at an increased risk for 
hereditary cancer.
 Timely communication - Any patient with questionable 
screening results is notified by phone in a timely 
manner.
 Next day biopsy results - 98 percent of biopsies are 
diagnosed by the next day.
 Weekly cancer treatment planning conferences - Every 
breast cancer diagnosis in our center is reviewed by an 
interdisciplinary team to determine the best course of 
treatment.
 Weekly benign correlation conferences - Benign 
findings are reviewed each week by an interdisciplinary 
team that correlates pathology and imaging results for a 
second reading.
 Large format pathology - This approach has been 
shown to decrease the need for re-excision and aims to 
lower the rate of breast cancer reoccurrence.
 Breast MRI - This advanced technology allows 
for precisely targeted treatment and aids in our 
multimodality imaging protocol.
 Bi-Weekly Breast Cancer Support Group - Facilitated 
by the advanced practice nurse and counselor every 
first and third Tuesday of each month.
  Early diagnosis and treatment are associated with 
improved survival from breast cancer.  Prior studies 
have demonstrated that there are variations in the times 
from detection to diagnosis, and diagnosis to treatment 
of breast cancer.  These variations are attributed to what 
other investigators have called the “patient delay” and 
the “system delay”[1,2].  
  System delays are those occurring within the 
healthcare system, such as scheduling appointments, 
follow-up, referrals, processing films, pathology reports, 
and reporting results[1,3,4].  Recent lay publications 
encourage women diagnosed with breast cancer to slow 
down the process to allow for digestion of information, 
investigation and self-education, seeking various 
medical opinions and options for treatment, and making 
well-informed and thoughtful decisions, suggesting that 
the “patient delay” may account for the variable time 
factor[5,6].  
  The purpose of this study was to assess the quality 
of care at the CCBCC, as defined by time intervals and 
efficiency; to determine the source (patient-based 
or system-based) of any delays associated with the 
turnaround time in our breast care continuum, and 
whether improvements can be made; and to understand 
what reasons patients may have to delay the process, 
and whether we can assist them to shorten these delays.
2. Materials and methods
2.1. Turnaround times
  A retrospective chart review was performed to evaluate 
the timeline from screening to treatment for breast 
cancer. All patients seen with breast cancer at the 
CCBCC less than 90 years old, and with a surgery date 
in the calendar year 2009 were included.  The patient 
population for this clinic closely mirrors the indigent 
population of adult and adolescent women in the greater 
Roanoke Valley: 49% White, 28% Black, 21% Hispanic, 
<1% Asian, 1% Unknown; Payer Mix:  53% Medicaid, 
31% Self-Pay, 7% Anthem, 5% Medicare, and 4% other. 
Patients were excluded if they were not diagnosed 
with breast cancer.  Time intervals in calendar days, 
including weekends, were calculated for the following 
time intervals: abnormal screening mammogram to 
diagnostic mammogram, diagnostic mammogram to 
biopsy, biopsy to MRI, and MRI to surgery. 
2.2. Statistical analysis
  A sample size of 121 achieves 80% power to detect 
non-inferiority using a one-sided Wilcoxon test 
assuming that the actual distribution is normal when 
the margin of equivalence is 1.4 (+10%) and the true 
difference between the mean and the reference value 
is 0.0.  The data are drawn from a single population 
with a standard deviation of 4.8.  The significance level 
(alpha) of the test is 0.012 5 to adjust for multiple tests[3]. 
The MEANS procedure was applied to evaluate the 
turnaround times.
  The national benchmark utilized for comparison was 
from the National Quality Measures for Breast Centers 
(NQMBC), established by the National Consortium of 
Breast Centers (NCBC), and published in 2010[7].  The 
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median time in days (business d) between screening and 
diagnostic mammogram was 6.5 (25%ile 4.0 d, 75%ile 
10.5 d); between diagnostic mammogram and needle 
biopsy was 6.0 d (25%ile 3.9 d, 75%ile 9.0 d); between 
needle biopsy and surgery was 14.0 d (25%ile 11.0 d, 
75%ile 19.5 d). 
2.3. Patient satisfaction
  
  An anonymous patient survey (Appendix) was mailed 
out to all patients managed at the CCBCC in 2009 
from the point of an abnormal screening mammogram 
through surgery.  Patients were excluded if they did not 
begin their evaluation with the CCBCC from screening 
mammogram through surgery; that is to say, any patients 
who were referred to the CCBCC for care anywhere in 
the process after an abnormal screening mammogram or 
more were performed elsewhere.  
  The patient survey assessed bi-modal patient 
satisfaction rates (Yes/No) with the turnaround times 
from screening mammogram to call back, call back 
to diagnostic mammogram, diagnostic mammogram 
to biopsy, biopsy to results call, biopsy result to MRI 
appointment, MRI appointment to surgery consult, and 
surgery consult to surgery, as well as assessed possible 
reasons why patients may have perceived the process to 
be delayed.  
2.4. Statistical analysis
  A Box and Whisker Plot statistical comparison was 
made between patient satisfaction and turnaround 
times. 
3. Results 
  One hundred ninety-eight (198) patients were treated 
for breast cancer with surgery in 2009. Of these, five 
patients had two mammogram procedure dates within 
this timeframe. These cases were researched and it 
was determined that they were FN.  They were deleted 
from the final analysis.  Four patients had neoadjuvant 
chemotherapy prior to surgery; one patient chose to 
delay surgery until her gardening was completed; one 
patient was being treated for a recurrent breast cancer; 
these patients were all deleted from the final analysis.  
   An additional 16 patients were considered to be 
outliers: 10 patients required specialty visits, i.e. second 
opinions, genetic testing, radiation oncology and/or 
reconstruction; four patients rescheduled surgery due to 
personal circumstances; one patient required a second 
consultation because the original surgeon became ill, 
which delayed her surgical procedure; and one patient 
could not be biopsied using conventional methods due 
to the lesion location. 
   An excisional biopsy was performed, which was 
positive for malignancy and had positive margins, which 
required a re-excision.  All 16 were included in the 
final analysis.  
  One hundred eighty-seven (187) patients were 
included in the final analysis.  The mean interval time 
for abnormal screening mammogram to diagnostic 
mammogram (SCRN to WKUP) was 13.19 calendar days 
(includes weekends); subtracting weekend days from 
the end of the interval forward equals 10 business days. 
The mean interval time for diagnostic mammogram to 
biopsy (WKUP to BPSY) was 3.92 days (calendar days 
equals business days).  
   The mean interval time for biopsy to MRI (BPSY to 
MRI) was 12.02; subtracting weekend days equals 10 
business days.  The mean interval time for MRI to 
surgery (MRI to SURG) was 35.06 d; subtracting weekend 
days equals 25 business days.  The mean interval time 
for abnormal screening mammogram to surgery (SCRN to 
SURG) was 61.24 d; subtracting weekend days equals 45 
business days (Table 1).
  Of the 131 surveys mailed out, 57 were returned (44%). 
Of 57 responses, 55 were satisfied with the interval 
screening to call-back (96%); of 57 responses, 57 were 
satisfied with the interval call-back to diagnostic 
appointment (100%); of 56 responses, 56 were satisfied 
with the interval diagnostic appointment to biopsy 
appointment (100%); of 55 responses, 54 were satisfied 
with the interval biopsy appointment to biopsy results 
call (98%); of 51 responses, 50 were satisfied with the 
interval biopsy results call to MRI appointment (98%); 
of 49 responses, 48 were satisfied with the interval 
Table 1. 
Summary statistics of time difference (in days) between selected procedures run the means procedure.
    n Mean Std dev Minimum Lower quartile Median Upper quartile Maximum
Interval=SCRN to WRKP   57 13.19   8.18       2   7 12 17   50
Interval=WRKP to BPSY 110   3.92 18.46 -180   2   5   7   43
Interval=BPSY to MRI   98 12.02   7.63   -12   9 11.5 14   68
Interval=MRI to SURG 123 35.06 30.6       3 20 27 41 221
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MRI appointment to surgery consult (98%); and of 55 
responses, 53 were satisfied with the interval surgery 
consult to actual surgery (96%).  Several surveys were 
marked in the margin indicating the patient had not had 
an MRI (Table 2).
  Combining the survey intervals to compare with 
turnaround time intervals, 98% were satisfied with the 
interval screening to diagnostic appointment (SCRN to 
WKUP), 100% were satisfied with diagnostic appointment 
to biopsy (WKUP to BPSY), 98% were satisfied with 
biopsy appointment to MRI (BPSY to MRI), 97% were 
satisfied with MRI appointment to surgery (MRI to 
SURG); an overall 98% were satisfied with the time from 
screening mammogram to surgery (SCRN to SURG) (Table 
2). 
Table 2.
Number and percentage of patients satisfied with turn-around time for 
selected intervals.
O r i g i n a l  i n t e r v a l s  f r o m 
questionnaire
Patients satisfied with turn around 
time 
Screening to call back 55/57 (96%)
Call back to Dx Appt 57/57 (100%)
Dx Appt to Bx Appt 56/56 (100%)
Bx Appt to Bx results call 54/55 (98%)
Bx cesults ball to MRI Appt 50/51 (98%)
MRI Appt to surgery consult 48/49 (98%)
Surgery consult to surgery 53/55 (96%)
Combined intervals
Screening to Dx Appt   98% 
Dx Appt to Bx Appt 100%
Bx Appt to MRI Appt   98%
MRI Appt to surgery   97%
Screening to surgery   98%
  Regarding patient perception of delay, 44 answers were 
registered on the patient surveys; 41 perceived there 
was no delay in the time from abnormal screening to 
surgery, two perceived there was a system delay, and 
one indicated she had imposed a delay (patient delay). 
4. Discussion
  The CCBCC falls within the 75%ile of the NQMBC 
benchmark (top 75%, 45 business days); however, 
this turnaround time included an interval of MRI, not 
previously measured in the NQMBC benchmark, which 
was established utilizing 2005 data[7]. This study also 
included all-comers to the CCBCC, which accounts 
for gaps in the interval data, as not all patients began 
or finished the process of screening to diagnosis to 
treatment with our institution. We noted that as the 
variation in time intervals increased, patient satisfaction 
decreased (Figure 1). 
   The MRI to surgery interval had a standard deviation 
of 30.6 d, by far the widest, and demonstrated the lowest 
combined satisfaction rate of 97%.  However, it must be 
acknowledged that overall; patients maintained a high 
satisfaction rate (96%-100% per individual intervals).
  Two significant rate-limiting steps were identified 
as the time from screening mammogram to diagnostic 
mammogram, and biopsy to surgery-specifically, the 
sub-interval MRI to surgery. The CCBCC turnaround 
time for screening to diagnostic mammogram was 10 d, 
compared with the NQMBC 50%ile of 6 d. 
  One patient indicated on her survey that, “Only the 
screening mammogram results were too slow. 3 weeks is 
too long.” This suggests an internal system delay, which 
could be improved by changing processes from within 
the Clinic.  
   The CCBCC turnaround time for biopsy to surgery was 
35 d, compared with the NQMBC 50%ile of 14 d. The 
benchmark states this interval includes biopsy results, 
surgery consultation, and surgery scheduling[7]. 
  At the CCBCC, this includes MRI, which added 10 
business days (BPSY to MRI), was the interval with the 
greatest variability, and the lowest patient satisfaction. 
In addition, the majority of consults were performed by 
one surgeon (at the time of the study).
Figure 1. Box-and-Whisker Plot.
   Several strengths of the CCBCC were also identified. 
The diagnostic mammogram to biopsy interval was 3.9 d, 
equal to the 25%ile of the NQMBC benchmark (top 25%). 
This interval had the lowest variability and the highest 
patient satisfaction. The primary breast surgeon’s 
re-excision rate is 6.7%, compared with the national 
average of 20%-60%[8-10].  
   It is suggested that the practice of the breast program 
with pre-treatment MRI adds days, but also clinical 
specificity in cancer treatment planning for the surgeon. 
In other words, the time spent obtaining the MRI is an 
opportunity cost for a significantly lower recurrence 
rate among our patients. Additionally, the CCBCC 
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demonstrates the unique model of a Clinical Nurse 
Navigator, who is personally involved with each patient, 
offering both clinical and emotional support: she assists 
with scheduling appointments, relaying results to 
patients, and organizes patient support groups.  Many 
patient surveys contained narrative comments reflecting 
the care and attention received at the Breast Care 
Center. 
  Since 2009, the CCBCC has already improved 
the process for obtaining insurance approval and 
preauthorization for MRIs (improves access); and has 
added clinical staff.  There is now an additional breast 
surgeon to share the burden of benign cases, and a nurse 
practitioner to see post-op and follow-up patients, both 
of which changes have improved the accessibility to the 
primary breast surgeon specialist. 
  Strengths of the study include its qualitative as well 
as quantitative analyses, retrospective as well as 
prospective arms, an excellent survey return rate of 
44%, the internal quality review this provides, and the 
first description of processes that incorporate MRI in 
turnaround times.  
  Potential limitations of the study include the 
incomplete data for Part 1 (i.e. missing dates for various 
appointments)-this is due to inclusion of some patients 
who received aspects of their care outside the CCBCC; 
calculation of business days from calendar days to 
compare Part 1 data with the national benchmark; the 
endpoints of the time intervals in Part 1 were different 
from Part 2 (survey includes sub-intervals not assessed 
in retrospective chart review); and the comparison of the 
CCBCC with a benchmark that does not include MRI, a 
key component in 2012 of standard breast cancer care. 
  These results demonstrate the need for future studies, 
not only of our Breast Care Center’s turnover times, 
including all sub-intervals in its evaluation, and 
limited to patients seen solely at the CCBCC; but also to 
establish a new national benchmark, including MRI in 
the screening to surgery process.
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